Swastik Drugs Pvt Ltd - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U02421MP1988PTC004662 Incorporated 17 June 1988 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma
Revenue · FY 2025
₹4.1 Lakh
▼ 17% YoY
Net profit · FY 2025
₹23,901
Net margin 5.8%
EBITDA · FY 2025
₹24,266
EBITDA margin 5.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
38 yrs
Est. 1988
Directors on board
4
As per MCA filings
GST registrations
1
None active

About Swastik Drugs Pvt Ltd

Data last updated:

Swastik Drugs Pvt Ltd is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 June 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U02421MP1988PTC004662. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Narendra Kumar Jain and Rakesh Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6/1 Sikh Mohalla, Indore, Madhya Pradesh, India – 452007.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.1 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹23,901 (net margin 5.8%) and EBITDA of ₹24,266 (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U02421MP1988PTC004662
Registration Number 004662
Incorporation Date 17 June 1988
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Swastik Drugs Pvt Ltd's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    6/1 Sikh Mohalla, Indore, Madhya Pradesh, India – 452007
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Swastik Drugs Pvt Ltd, buy the company report.

Comprehensive company report
Swastik Drugs Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Swastik Drugs is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Swastik Drugs Pvt Ltd, buy the company report.

Financials of Swastik Drugs Pvt Ltd

FY 2025 filings available

Swastik Drugs Pvt Ltd reported revenue of ₹4.1 Lakh (down 17% YoY) for FY 2025.

Revenue · FY 2025
₹4.1 Lakh ▼ 17%
Net profit · FY 2025
₹23,901 margin 5.8%
EBITDA · FY 2025
₹24,266 margin 5.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 12%
5 years · compounded
▲ 98%

Revenue fell 17% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹24,266
Profit Before Tax
Tax Expense
Net Profit (PAT)₹23,901
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.9%
Net Profit Margin5.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Swastik Drugs Pvt Ltd, buy the company report.

Board of directors of Swastik Drugs Pvt Ltd

Swastik Drugs has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Narendra Kumar JainDirector17 Jun 198838 Years 5 MonthsCurrent
Rakesh JainDirector17 Jun 198838 Years 5 MonthsCurrent
Azad Kumar JainDirector17 Jun 198838 Years 5 MonthsCurrent
Rajeev JainDirector16 Aug 200125 Years 3 MonthsCurrent

Peer comparison

Swastik Drugs Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Steeford Pharmaceuticals Private Limited₹4.16 Lakh (FY 2025)14.0%Gorakhpur, Uttar Pradesh, India
G.K. Pharmaceuticals Pvt.Ltd.₹4.15 Lakh (FY 2022)63.0%Telangana, India
Biokol Medical Private Limited₹4.14 Lakh (FY 2025)-88.0%New Delhi, Delhi, India
Swastik Drugs Pvt Ltdthis company₹4.1 Lakh (FY 2025)₹23,9015.8%-17.0%Indore, Madhya Pradesh, India
Baba Mohan Ram Pharma Private Limited₹4.08 Lakh (FY 2025)-17.0%Noida, Uttar Pradesh, India
Iwaantra Biological Private Limited₹4.06 Lakh (FY 2025)-8.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Swastik Drugs Pvt Ltd, buy the company report.

Auditor

Swastik Drugs Pvt Ltd is audited by Prabhat Rathi & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Prabhat Rathi & AssociatesFY 2023009520C

Shareholding

The shareholding of Swastik Drugs Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Swastik Drugs Pvt Ltd, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Swastik Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Swastik Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Swastik Drugs Pvt Ltd, buy the company report.

Recent activity

Swastik Drugs Pvt Ltd has 4 board changes on record since 1988: 4 appointments. The latest: Rajeev Jain was appointed as Director on 16 Aug 2001.

AGM
Swastik Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Swastik Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Rajeev Jain was appointed as Director.
Appointed
Azad Kumar Jain was appointed as Director.
Appointed
Narendra Kumar Jain was appointed as Director.
Appointed
Rakesh Jain was appointed as Director.
Incorporation
17 Jun 1988
Swastik Drugs Pvt Ltd was registered on 17 Jun 1988 with Roc Gwalior & aged 38 years 5 months as per MCA records.

Frequently asked questions

Swastik Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 June 1988 (38+ years old) and is registered under CIN U02421MP1988PTC004662.

Swastik Drugs has 4 current directors:

The latest financial statements of Swastik Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

No. Swastik Drugs has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Swastik Drugs is U02421MP1988PTC004662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Swastik Drugs was incorporated on 17 June 1988, making it 38+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Swastik Drugs by revenue are Steeford Pharmaceuticals Private Limited, G.K. Pharmaceuticals Pvt.Ltd, Biokol Medical Private Limited, Baba Mohan Ram Pharma Private Limited, Iwaantra Biological Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Rajeev Jain was appointed as Director on 16 Aug 2001. Azad Kumar Jain was appointed as Director on 17 Jun 1988. Narendra Kumar Jain was appointed as Director on 17 Jun 1988. Swastik Drugs has 4 board changes on record in total.

The registered office of Swastik Drugs is at 61 Sikh Mohalla, Indore, Madhya Pradesh, India – 452007.

Swastik Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Swastik Drugs is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.